Physician profile
Jason B Fields
NPI 1639289101
$26,223.54
in general payments reported to CMS, 2019-2025
9 companies · $5,887 in 2025
The $5,887 reported for 2025 was more than what 96% of Addiction Psychiatry providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,539 · 2022: $287 · 2023: $175 · 2024: $121 · 2025: $5,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,416 · Travel and Lodging: $908 · Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,416.00 |
| Travel and Lodging | $907.94 |
| Food and Beverage | $859.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $19,806.21 | 2019-2025 | Aristada, Vivitrol, Aristada Initio |
| Indivior INC. | $6,026.57 | 2022-2025 | Sublocade |
| Janssen Pharmaceuticals, INC | $91.07 | 2022-2023 | Invega Sustenna, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $80.09 | 2023-2025 | Uzedy |
| E.R. Squibb & Sons, L.L.C. | $74.41 | 2024-2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $62.02 | 2023-2025 | Ingrezza |
| Braeburn INC. | $46.18 | 2024-2025 | Brixadi |
| Orexo US, INC. | $21.43 | 2023 | Zubsolv |
| Noven Therapeutics, LLC | $15.56 | 2024 | Xelstrym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.